UBS AM’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Sell |
111,362
-75,032
| -40% | -$1.73M | ﹤0.01% | 2036 |
|
|
2025
Q1 | $5.03M | Buy |
186,394
+20,657
| +12% | +$558K | ﹤0.01% | 1571 |
|
|
2024
Q4 | $8.87M | Buy |
165,737
+139,543
| +533% | +$7.47M | ﹤0.01% | 1307 |
|
|
2024
Q3 | $1.19M | Sell |
26,194
-3,984
| -13% | -$181K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $1.26M | Buy |
30,178
+21,483
| +247% | +$900K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $327K | Buy |
+8,695
| New | +$327K | ﹤0.01% | 2384 |
|